0.1800
+0.0080
+(4.65%)
At close: April 17 at 5:35:01 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-10,620
-12,873
-18,988
-23,795
-9,743
Investing Cash Flow
1,138
370
-17
12,160
-12,713
Financing Cash Flow
5,918
7,027
6,134
29,715
21,953
End Cash Position
2,175
5,568
11,053
23,926
5,847
Capital Expenditure
-139
-220
-141
-344
-214
Issuance of Capital Stock
3,238
5,541
--
16,584
23,486
Issuance of Debt
4,000
1,890
9,510
20,484
8,730
Repayment of Debt
-1,492
-1,545
-2,088
-3,604
-4,077
Free Cash Flow
-10,759
-13,093
-19,129
-24,139
-9,957
12/31/2020 - 7/13/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ALNEV.PA Neovacs S.A.
0.0219
-3.52%
ALTHX.PA Theranexus Société Anonyme
0.3940
+0.69%
ALTAO.PA ATON
0.0098
+3.16%
SIGHT.PA GenSight Biologics S.A.
0.2265
-1.95%
VICO.ST Vicore Pharma Holding AB (publ)
6.32
0.00%
ALSEN.PA Sensorion SA
0.1700
-26.09%
CYAD.BR Celyad Oncology SA
0.5400
-6.90%
GNFT.PA Genfit S.A.
3.0700
-1.98%
POXEL.PA Poxel S.A.
0.3810
-22.56%
DBV.PA DBV Technologies S.A.
1.3280
+3.59%